Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
18.4M
-
Shares change
-
-16.5M
-
Total reported value, excl. options
-
$81.7M
-
Value change
-
-$100M
-
Put/Call ratio
-
0.35
-
Number of buys
-
21
-
Number of sells
-
-28
-
Price
-
$4.45
Significant Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q4 2015
62 filings reported holding ABUS - Arbutus Biopharma Corp - Common Shares, without par value as of Q4 2015.
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4M shares
of 193M outstanding shares and own 9.49% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (2.93M shares), Falcon Edge Capital LP (2.62M shares), HealthCor Management, L.P. (2.19M shares), D. E. Shaw & Co., Inc. (1.87M shares), FRANKLIN RESOURCES INC (1.29M shares), MILLENNIUM MANAGEMENT LLC (1.2M shares), SABBY MANAGEMENT, LLC (1M shares), AXA (781K shares), BANK OF MONTREAL /CAN/ (770K shares), and GOLDMAN SACHS GROUP INC (675K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.